Henricus Broxterman

DR.

19952018
If you made any changes in Pure these will be visible here soon.

Research Output 1995 2018

  • 20 Article
  • 1 Chapter
  • 1 Meeting Abstract
  • 1 Research VU University Amsterdam, graduation VU University Amsterdam
Filter
Article
Article

Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature

Gotink, K. J., Broxterman, H. J., Honeywell, R. J., Dekker, H., de Haas, R. R., Miles, K. M., Adelaiye, R., Griffioen, A. W., Peters, G. J., Pili, R. & Verheul, H. M. W., 2014, In : Oncoscience. 1, 12, p. 844-853

Research output: Contribution to journalArticleAcademicpeer-review

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer

Wentink, M. Q., Broxterman, H. J., Lam, S. W., Boven, E., Walraven, M., Griffioen, A. W., Pili, R., van der Vliet, H. J., de Gruijl, T. D. & Verheul, H. M. W., 11 Oct 2016, In : British Journal of Cancer. 115, 8, p. 940-948

Research output: Contribution to journalArticleAcademicpeer-review

Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2

Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M. & Jansen, G., 1 Jun 1999, In : Cancer Research. 59, 11, p. 2532-5 4 p.

Research output: Contribution to journalArticleAcademicpeer-review

42 Downloads (Pure)

CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients

Vroling, L., Lind, J. S. W., de Haas, R. R., Verheul, H. M. W., van Hinsbergh, V. W. M., Broxterman, H. J. & Smit, E. F., 2010, In : British Journal of Cancer. 102, 2, p. 268-275

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File

CD133+hematopoietic progenitor cells in non-small cell lung cancer patients as indicator of an anti-angiogenic therapeutic response

Vroling, L., Lind, J. S. W., Smit, E. F., Verheul, H. M. W., Haas, RJ. & Broxterman, H. J., 2009, In : Journal of Thoracic Oncology. 4, 9, p. S501-S501

Research output: Contribution to journalArticleAcademicpeer-review

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib

Gotink, K. J., Rovithi, M. N., de Haas, R. R., Honeywell, R. J., Dekker, H., Poel, D., Azijli, K., Peters, G. J., Broxterman, H. J. & Verheul, H. M. W., 2015, In : Cellular Oncology. 38, 2, p. 119-129

Research output: Contribution to journalArticleAcademicpeer-review

Hypoxia Impairs Initial Outgrowth of Endothelial Colony Forming Cells and Reduces Their Proliferative and Sprouting Potential

Tasev, D., Dekker-Vroling, L., van Wijhe, M., Broxterman, H. J., Koolwijk, P. & van Hinsbergh, V. W. M., 20 Dec 2018, In : Frontiers in medicine. 5, 356.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
39 Downloads (Pure)

Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib

Vroling, L., van der Veldt, A. A. M., de Haas, R. R., Haanen, J. B., Schuurhuis, G. J., Kuik, D. J., van Cruijsen, H., Verheul, H. M. W., van den Eertwegh, A. J. M., Hoekman, K., Boven, E., van Hinsbergh, V. W. M. & Broxterman, H. J., 2009, In : Angiogenesis. 12, 1, p. 69-79

Research output: Contribution to journalArticleAcademicpeer-review

File

Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance

Gotink, K. J., Broxterman, H. J., Labots, M., de Haas, R. R., Dekker, H., Honeywell, R. J., Rudek, M. A., Beerepoot, L. V., Musters, R. J. P., Jansen, G., Griffioen, A. W., Assaraf, Y. G., Pili, R., Peters, G. J. & Verheul, H. M. W., 2011, In : Clinical Cancer Research. 17, 23, p. 7337-7346

Research output: Contribution to journalArticleAcademicpeer-review

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

Shapira, A., Livney, Y. D., Broxterman, H. J. & Assaraf, Y. G., 2011, In : Drug Resistance Updates. 14, 3, p. 150-163

Research output: Contribution to journalArticleAcademicpeer-review

Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms

van der Mijn, J. C., Mier, J. W., Broxterman, H. J. & Verheul, H. M., 2014, In : Drug Resistance Updates. 17, 4-6, p. 77-88

Research output: Contribution to journalArticleAcademicpeer-review

Proteomics of the TRAP-induced platelet releasate

Piersma, S. R., Broxterman, H. J., Kapci, M., Haas, RJ., Hoekman, K., Verheul, H. M. W. & Jimenez, C. R., 2009, In : Journal of Proteomics. 72, 1, p. 91-109

Research output: Contribution to journalArticleAcademicpeer-review

Sunitinib activates Axl signaling in renal cell cancer

van der Mijn, J. C., Broxterman, H. J., Knol, J. C., Piersma, S. R., De Haas, R. R., Dekker, H., Pham, T. V., Van Beusechem, V. W., Halmos, B., Mier, J. W., Jimenez, C. R. & Verheul, H. M. W., 15 Jun 2016, In : International Journal of Cancer. 138, 12, p. 3002-3010

Research output: Contribution to journalArticleAcademicpeer-review

Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer

van der Veldt, A. A. M., Vroling, L., de Haas, R. R., Koolwijk, P., van den Eertwegh, A. J. M., Haanen, J. B. A. G., van Hinsbergh, V. W. M., Broxterman, H. J. & Boven, E., 2012, In : International Journal of Cancer. 131, 4, p. E484-E493

Research output: Contribution to journalArticleAcademicpeer-review

Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule

van der Veldt, A. A. M., Boven, E., Vroling, L., Broxterman, H. J., van den Eertwegh, A. J. M. & Haanen, JB., 2009, In : Journal of Clinical Oncology. 27, 8, p. 1339-1340

Research output: Contribution to journalArticleAcademicpeer-review

Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival

van Cruijsen, H., van der Veldt, A. A. M., Vroling, L., Oosterhoff, D., Broxterman, H. J., Scheper, R. J., Giaccone, G., Haanen, J. B., van den Eertwegh, A. J. M., Boven, E., Hoekman, K. & de Gruijl, T. D., 2008, In : Clinical Cancer Research. 14, 18, p. 5884-5892

Research output: Contribution to journalArticleAcademicpeer-review

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

Broxterman, H. J., Gotink, K. J. & Verheul, H. M. W., 2009, In : Drug Resistance Updates. 12, 4-5, p. 114-126

Research output: Contribution to journalArticleAcademicpeer-review

VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients

Vroling, L., Yuana, Y., Schuurhuis, G. J., van Hinsbergh, V. W. M., Gundy, C., de Haas, R., van Cruijsen, H., Boven, E., Hoekman, K. & Broxterman, H. J., 1 Aug 2007, In : Thrombosis and Haemostasis. 98, 2, p. 440-450 11 p.

Research output: Contribution to journalArticleAcademicpeer-review